16 results
20-F
2020 FY
AMYT
Amryt Pharma Plc
30 Apr 21
Annual report (foreign)
12:53pm
, or to discontinue the clinical trials altogether;
delays in necessary interactions with local regulators, ethics committees and other important agencies … candidates, we, the FDA, competent authorities of EU Member States, ethics committees, the IRBs, the institutions in which our studies are conducted
424B4
AMYT
Amryt Pharma Plc
14 Jan 21
Prospectus supplement with pricing info
9:30am
altogether;
delays in necessary interactions with local regulators, ethics committees and other important agencies and contractors due to limitations … side effects arise in the development of our product candidates, we, the FDA, competent authorities of EU Member States, ethics committees
F-1/A
AMYT
Amryt Pharma Plc
12 Jan 21
Registration statement (foreign) (amended)
12:00am
, or to discontinue the clinical trials altogether;
delays in necessary interactions with local regulators, ethics committees and other important agencies … Member States, ethics committees, the institutional review boards, at the institutions in which our studies are conducted, or the DSMB, could suspend
F-1
xgykbm25
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
6o9ou0 o44v
18 Dec 20
Draft registration statement
12:00am
424B4
unhjqhsmc4 vb
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
601aj
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
id75yf
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.12.5
iatknip87hl0p2c
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.12.1
2uoe2
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
oyppe2 mg42c1mj
29 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.12
8j9kl805r
11 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.12
0jz80j7xcl1pctdafx
11 May 20
Draft registration statement (amended)
12:00am
DRS
nxiorsupj8yfwt4 ruv0
19 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next